Somewhat Positive News Coverage Somewhat Unlikely to Affect USA Technologies (USAT) Stock Price

News stories about USA Technologies (NASDAQ:USAT) have trended somewhat positive this week, according to Accern Sentiment Analysis. The research firm ranks the sentiment of media coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. USA Technologies earned a daily sentiment score of 0.14 on Accern’s scale. Accern also gave media headlines about the technology company an impact score of 45.2351963086193 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

These are some of the news stories that may have effected Accern Sentiment Analysis’s rankings:

How to Become a New Pot Stock Millionaire

A number of brokerages have issued reports on USAT. Zacks Investment Research cut USA Technologies from a “buy” rating to a “hold” rating in a report on Tuesday, February 13th. BidaskClub cut USA Technologies from a “hold” rating to a “sell” rating in a report on Tuesday, April 10th. Barrington Research reissued a “buy” rating on shares of USA Technologies in a report on Tuesday, April 3rd. Northland Securities set a $12.00 price objective on USA Technologies and gave the company a “buy” rating in a report on Monday, December 18th. Finally, Lake Street Capital began coverage on USA Technologies in a report on Tuesday, April 3rd. They set a “buy” rating and a $11.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $11.67.

Shares of NASDAQ USAT traded up $0.22 during midday trading on Tuesday, reaching $8.97. 168,809 shares of the company traded hands, compared to its average volume of 477,741. The stock has a market cap of $466.70, a PE ratio of -446.00 and a beta of 0.59. USA Technologies has a 12 month low of $4.25 and a 12 month high of $10.10. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.36.

USA Technologies (NASDAQ:USAT) last issued its quarterly earnings data on Thursday, February 8th. The technology company reported $0.02 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.01 by $0.01. The company had revenue of $32.51 million during the quarter, compared to analysts’ expectations of $31.38 million. USA Technologies had a positive return on equity of 2.18% and a negative net margin of 10.39%. analysts predict that USA Technologies will post 0.06 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “Somewhat Positive News Coverage Somewhat Unlikely to Affect USA Technologies (USAT) Stock Price” was originally reported by Zolmax and is the sole property of of Zolmax. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece can be read at https://zolmax.com/investing/somewhat-positive-news-coverage-somewhat-unlikely-to-affect-usa-technologies-usat-stock-price/2112436.html.

USA Technologies Company Profile

USA Technologies, Inc provides wireless networking, cashless transactions, asset monitoring, and other value-added services in the United States and internationally. It designs and markets systems and solutions that facilitate electronic payment options, as well as telemetry and machine-to-machine (M2M) services.

Insider Buying and Selling by Quarter for USA Technologies (NASDAQ:USAT)

Receive News & Ratings for USA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Synergy Pharmaceuticals  Earns News Sentiment Rating of 0.05
Synergy Pharmaceuticals Earns News Sentiment Rating of 0.05
UMH Properties  Given Daily Media Sentiment Rating of 0.19
UMH Properties Given Daily Media Sentiment Rating of 0.19
Somewhat Positive News Coverage Somewhat Unlikely to Affect USA Technologies  Stock Price
Somewhat Positive News Coverage Somewhat Unlikely to Affect USA Technologies Stock Price
Ashmore Group’s  “Buy” Rating Reaffirmed at Canaccord Genuity
Ashmore Group’s “Buy” Rating Reaffirmed at Canaccord Genuity
Zacks: Brokerages Expect PepsiCo  Will Announce Quarterly Sales of $12.42 Billion
Zacks: Brokerages Expect PepsiCo Will Announce Quarterly Sales of $12.42 Billion
Evolent Health  Given Consensus Rating of “Buy” by Analysts
Evolent Health Given Consensus Rating of “Buy” by Analysts


Leave a Reply

 
© 2006-2018 Zolmax.